Rescheduling Cannabis at the Federal Level
This topic surfaced in May 2024. Wow, how long has it been out there?
In the United States, the Controlled Substance Act (CSA) designated cannabis as a Schedule I drug in 1970, during the Nixon era. Now, more than fifty years later, over half the states have made cannabis legal at the state level, and approximately three-quarters of the U.S. population have positive feelings about cannabis. The powers that be in Washington are getting around to legalizing cannabis at the federal level in some form now, in 2024.
The front-page news is that the Drug Enforcement Agency (DEA) is now considering moving cannabis from a Schedule I to a Schedule III drug. That was on May 1st. On May 2nd, the leadership of the U.S. Senate held a news conference with a proposed Senate Bill to address cannabis. So, two competing alternatives are now “on the table.”
The following posts explore the impacts and implications on the Cannabis Industry.
BOLDLY | GO: Meet the Panelists for the Cannabis Presentation at Scaling New Heights 2024
As posted May 23, 2024 on The Woodard Report Visit Bruce's articles channel on The Woodard Report HERE. Please [...]
Cannabis Rescheduling at the Federal Level – What to Expect
As posted May 21, 2024 on The Woodard Report Visit Bruce's articles channel on The Woodard Report HERE. This [...]
Rescheduling Cannabis through DEA – its impact on IRC 280E
On May 1, 2024, the Drug Enforcement Agency of the federal US government (“DEA”) announced it was in serious consideration [...]